Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Comment by Alba1314on Aug 23, 2018 7:50am
78 Views
Post# 28504154

RE:RE:RE:I've Noticed...

RE:RE:RE:I've Noticed...I usually don't resort to this but you're an idiot. Speculating on the terms of financing (not if) is a part of investing an financing! And the ideas where were sharing were constructive. There was no bashing or fear mongering.I'm sure there are many like me that are considering investing more and want to make sure that investment is timed right. The next catalyst is how the Phase II/III trials are going to be financed. Why put money in now when the price may drop due to dilution? The converse to that, of course, is get in now before it goes up. And that's what some of us are discussing. We're not like you, prancing around like Richard Simmons saying "stay strong everyone...stay strong!" and ignoring facts (I can end a post with snively comments like you too)


<< Previous
Bullboard Posts
Next >>